Search research articles
Contact Us
Filters
Showing results (601-610 of 638) with videos related to
Page
of 64
Sort By:
Wellcome Open Research
|
March 4, 2022
Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments
Tina Habota, Anca-Larisa Sandu, Gordon D Waiter, et al.
The Journal of Infectious Diseases
|
February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
Molecular Psychiatry
|
August 29, 2023
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
Nerisa Banaj, Daniela Vecchio, Fabrizio Piras, et al.
JAMA Psychiatry
|
June 24, 2026
Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis
Bridget King, Kirsten Borup Bojesen, Charlotte Crisp, et al.
Schizophrenia Bulletin
|
August 15, 2023
Psychosis Endophenotypes: A Gene-Set-Specific Polygenic Risk Score Analysis
Baihan Wang, Haritz Irizar, Johan H Thygesen, et al.
JCI Insight
|
October 5, 2021
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Angela M Minassian, Yrene Themistocleous, Sarah E Silk, et al.
JCI Insight
|
November 3, 2017
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth O Payne, Sarah E Silk, Sean C Elias, et al.
Nature Medicine
|
December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Med (New York, N.Y.)
|
July 5, 2021
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M Minassian, Sarah E Silk, Jordan R Barrett, et al.
Page
of 64
Search research articles
Search
Showing results (601-610 of 638) with videos related to
Sort By:
Page
of 64
Wellcome Open Research
|
March 4, 2022
Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments
Tina Habota, Anca-Larisa Sandu, Gordon D Waiter, et al.
The Journal of Infectious Diseases
|
February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
Molecular Psychiatry
|
August 29, 2023
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
Nerisa Banaj, Daniela Vecchio, Fabrizio Piras, et al.
JAMA Psychiatry
|
June 24, 2026
Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis
Bridget King, Kirsten Borup Bojesen, Charlotte Crisp, et al.
Schizophrenia Bulletin
|
August 15, 2023
Psychosis Endophenotypes: A Gene-Set-Specific Polygenic Risk Score Analysis
Baihan Wang, Haritz Irizar, Johan H Thygesen, et al.
JCI Insight
|
October 5, 2021
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Angela M Minassian, Yrene Themistocleous, Sarah E Silk, et al.
JCI Insight
|
November 3, 2017
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth O Payne, Sarah E Silk, Sean C Elias, et al.
Nature Medicine
|
December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Med (New York, N.Y.)
|
July 5, 2021
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M Minassian, Sarah E Silk, Jordan R Barrett, et al.
Page
of 64